Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening

Official Title

Determination and Validation of Lung EpiCheck®: A Multianalyte Assay for Lung Cancer Prediction. A Case-Control Study


This study is part of the development and validation of a non-invasive lung screening test which aim to identify early stage lung cancer in patients at high risk for lung cancer.

Trial Description

Primary Outcome:

  • Collection of blood samples
  • Clinical data collection
Secondary Outcome:
  • Performance
  • Sensitivity
  • Specificity
  • Negative Predictive Value
  • Positive Predictive Value
This is a prospective, case-control, multi-centre, observational nonsignificant risk study. The study aims to collect blood and clinical data from subjects undergoing Low Dose CT (LDCT) for lung cancer screening and subjects with confirmed lung cancer.

View this trial on

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.


Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society